Drug Shortage Report for SEPTRA INJECTION

Last updated on 2020-12-22 History
Report ID 129261
Drug Identification Number 00550086
Brand name SEPTRA INJECTION
Common or Proper name Septra Injection (sulfamethoxazole 80mg/mL - trimethoprim 16mg/mL (5mL/ampoule))
Company Name ASPEN PHARMACARE CANADA INC.
Market Status MARKETED
Active Ingredient(s) TRIMETHOPRIM SULFAMETHOXAZOLE
Strength(s) 16MG 80MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 10 Ampoule
ATC code J01EE
ATC description SULFONAMIDES AND TRIMETHOPRIM
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2020-12-02
Estimated end date 2020-12-16
Actual end date 2020-12-22
Shortage status Resolved
Updated date 2020-12-22
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 2030 BRISTOL CIRCLE, SUITE 201
OAKVILLE, ONTARIO
CANADA L6H 0H2
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2020-12-22 French Compare
v4 2020-12-22 English Compare
v3 2020-12-03 English Compare
v2 2020-12-02 French Compare
v1 2020-12-02 English Compare

Showing 1 to 5 of 5